The Anatomic Pathology Market size is expected to grow at an annual average of 7% during 2021-2027. Anatomical pathology, or Commonwealth, is a medical specialization related to the diagnosis of diseases based on macroscopic, microscopic, biochemical, immunological, and molecular examination of organs and tissues. Anatomical pathology communicates the treatment, examination, and diagnosis of surgical cases by a doctor trained in pathological diagnosis.
(Get 15% Discount on Buying this Report)
A full report of Anatomic Pathology Market is available at: https://www.orionmarketreports.com/anatomic-pathology-market/54269/
The following segmentation are covered in this report:
By Product & Service
- Services
- Instruments
- Consumables
By Application
- Disease Diagnosis
- Cancer
- Other Diseases (Includes HBV, Epstein-Barr Virus, Liver Diseases, Muscular Dystrophy, and Gastroesophageal Reflux Disease)
- Medical Research
By End-User
- Hospital Laboratories
- Clinical Laboratories
- Other End Users
Company Profile
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Hoffmann-La Roche Ltd.
- Agilent Technologies, Inc.
- Cardinal Health
- Sakura Finetek USA, Inc.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Anatomic Pathology Market
- The market share of the global Anatomic Pathology Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Anatomic Pathology Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Anatomic Pathology Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
